Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke. The HALTI Trial

NCT04475510 is registered in ClinicalTrials.gov with Josep Rodes-Cabau as lead sponsor.

NCT NCT04475510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04475510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke. The HALTI Trial
Lead sponsor
Josep Rodes-Cabau
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2020
Completion date
August 1, 2032
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding ulcer, ischemic stroke, patent foramen ovale